For millions living with pattern hair loss, existing treatments offer little more than a pause button—delaying progression ...

The researchers used mouse skin samples to monitor changes to the fat tissue under the skin, as well as to the hair follicles and the cells that help hair grow, after they caused ...

In 2024, scientists stumbled upon a potential new treatment for hereditary-patterned baldness, the most common cause of hair loss in both men and women worldwide. It all started with research on a ...

Baricitinib (Olumiant; Eli Lilly), an oral Janus kinase (JAK) 1/2 inhibitor, led to significant scalp, eyelash, and eyebrow hair regrowth at 52 weeks in adolescents with severe alopecia areata, ...

At 1 year, results showed 45.1% of patients receiving baricitinib 4mg and 31% of patients receiving baricitinib 2mg achieved successful hair regrowth (SALT ≤20). Long term data were announced from a ...